You Position: Home > Paper
Improving long-term outcomes of coronary intervention in patients with diabetes
( views:100, downloads:4 )
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 6
- DOI:
- 10.3760/cma.j.issn.0366-6999.2009.06.001
- Key Word:
- No keyword available
Abstract： @@ In China, the prevalence of type 2 diabetes mellitus is increasing due to the aging of the population, increased frequency of obesity, and suboptimal nutritional habits1The current number of diabetic patients in China is around 40 million. Patients with diabetes even without prior cardiovascular disease have the same event rates as individuals without diabetes but with nrior myocardial infarction.2
- [1]YANG Yue-jin,XU Bo,KANG Sheng,etc.Comparison of in-hospital and long-term outcomes between a Cypher stent and a Taxus stent in Chinese diabetic patients with coronary artery disease[J].2007,(21).
- [2]Cook S,Wandel S,Meier B,etc.Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.[J].2008,29(6).
- [3]Brar SK,Mansukhani P,Brar SS,etc.Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.[J].2008,51(23).
- [4]Chun KJ,Lee SW,Kim HS,etc.A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus.[J].2008,52(9).
- [5]Kastrati A,Pache J,von Beckerath N,etc.Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.[J].2005,353(7).
- [6]Mahmud E,Ang L,Bromberg-Marin G,etc.Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.[J].2008,51(25).
- [7]Jensen LO,Thayssen P,Hansen KN,etc.Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.[J].2008,29(22).
- [8]Neil HA,Holman RR,Paul SK,etc.Long-term follow-up after tight control of blood pressure in type 2 diabetes.[J].2008,359(15).
- [9]Marzaroli P,Ortolani P,Sangiorgio P,etc.Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.[J].2008,117(7).
- [10]Murray GD,Skene AM,Scheen A,etc.Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.[J].2005,366(9493).
- [11]Daemen J,Kuck KH,Macaya C,etc.Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.[J].2008,52(24).
- [12]Fleg JL,Howard BV,Stylianou M,etc.Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.[J].2008,52(25).
- [13]Schramm TK,Gislason GH,Kober L,etc.Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.[J].2008,117(15).
- [14]Lange RA,Michos ED,Ardehali H,etc.Aspirin and clopidogrel resistance.[J].2006,81(4).